Loading
Latest filing published 09 Oct 2026 for NEOGEN CORP, €5,375. Read the official filing
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mikheal Nassif discloses dealings in Neogen Corp to SEC (Form 4). Between 15 August 2025 and 9 October 2026, the trades on record add up to 9 filings.
No open-market sale appears; the market trades are 6 purchases worth €12k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants. In 2026 alone, the filings show 5 purchases and no sales.
A typical purchase (the median) is worth €1,031. Across 6 purchases, this insider has always bought alone, with no colleague buying within 30 days. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 50% of cases; the median change was -4.9%. These figures describe past trades and do not predict future prices.
Most recently, on 9 October 2026, the filings show an open-market purchase worth €5,375 in Neogen Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations